Ray D. Page, DO, PhD, FACOI, FASCO, has practiced medical oncology for 23 years. He is President of The Center for Cancer and Blood Disorders and has been at the forefront of community oncology practice transformation participating in a variety of payment reform models and development of pathway systems. As Director of Research for The Center for Cancer and Blood Disorders, Dr. Page has been the Principal Investigator of over 200 clinical trials. He serves on the board, executive committee, and chairs the membership committee of a national oncology “Supergroup”, Quality Cancer Care Alliance. He is the Chief-of-Staff and serves on several committees, including the Graduate Medical Education Committee for the Internal Medicine residency program, and serves on the Board of the Careity Foundation in Fort Worth, Texas.

Dr. Page received his BS in chemistry and biology from Southwestern University in Georgetown, Texas and his MS in physiology at Baylor University Graduate School-Baylor College of Dentistry in Dallas, Texas. He received his Ph.D. in pharmacology and his doctorate in osteopathic medicine. Dr. Page completed his residency in internal medicine at The University of North Texas Health Science Center Osteopathic Medical Center of Texas and completed a combined oncology/hematology fellowship at the University of Texas M. D. Anderson Cancer Center in Houston, Texas.

Sucharu Prakash, MD, currently serves on the Texas Medical Association (TMA) Committee on Cancer. The committee supervises TMA’s cancer-related activities, educates physicians and patients about cancer, and works with other groups on cancer-related care and issues. As an oncology expert serving on the committee, Dr. Prakash can speak to cancer prevention and risk education, screenings and early detection, diagnosis, treatment, quality of life, and survivorship.

In addition to his TMA involvement, Dr. Prakash also serves on the board of directors for Texas Oncology and is the regional medical director in the Paris, Mount Pleasant, and Greenville areas. He is the principal investigator for research trials at Texas Oncology – Paris, and is a member of the US Oncology Breast Cancer Research Committee.